Rosuvastatin in African Americans With Cerebrovascular Disease

Stopped early · Phase 4

Conditions studied: Stroke, Transient Ischemic Attack

In brief

This study will assess the rate at which rosuvastatin will achieve LDL targets in African American patients with previous history of stroke or TIA.

Key facts

Study ID

NCT01975194

Run by

Wayne State University

People needed

20

Starts

2012-01-01

Expected to finish

2013-08-01

Last updated by the study team

2013-11-05

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 30 and above
• Rankin score of ≤ 3
• Patient has a fixed telephone number and is available for follow-up
• African American
• Diagnosis of ischemic stroke or TIA in past 12 months

You may not qualify if…

• Liver enzyme abnormalities (ALT or AST >2x ULN)
• Known muscle disorder or CK > 5x ULN
• Alcoholism or substance abuse
• Stroke due to dissection or hypercoagulable state
• Moderate to severe dementia (MMSE <20)
• On hemodialysis
• No fixed home address

Where it is running

• Detroit Medical Center — Detroit, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.